# FDA Inspection 1067666 - Biomat USA, Inc. - September 27, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8e27149b-8c9d-4dcd-abd6-693b06153ef5
Source feed: FDA_Inspections

> FDA Inspection 1067666 for Biomat USA, Inc. on September 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067666
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 945017 - 2015-09-01](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/5f556040-bfc6-4e2b-80cd-9908651a6757)
- [FDA Inspection 800788 - 2012-09-20](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a91bc93c-ec45-4a7c-81f9-5c04068e048c)
- [FDA Inspection 709365 - 2011-02-10](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/c2f82fcd-2a13-49bd-9ca4-3da94c83f962)
- [FDA Inspection 601894 - 2009-07-24](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/92a3b241-7cad-49f7-bd64-22a3bdbdec3b)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/71a2cbe7-198f-48a6-82a3-5a76c181d849

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d